nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluorouracil—ABCG2—Riluzole—amyotrophic lateral sclerosis	0.476	0.708	CbGbCtD
Fluorouracil—CYP1A2—Riluzole—amyotrophic lateral sclerosis	0.196	0.292	CbGbCtD
Fluorouracil—Proctitis—Riluzole—amyotrophic lateral sclerosis	0.0129	0.0872	CcSEcCtD
Fluorouracil—Pericarditis—Riluzole—amyotrophic lateral sclerosis	0.00729	0.0492	CcSEcCtD
Fluorouracil—Blepharitis—Riluzole—amyotrophic lateral sclerosis	0.00512	0.0346	CcSEcCtD
Fluorouracil—UPP2—nervous system—amyotrophic lateral sclerosis	0.00446	0.0597	CbGeAlD
Fluorouracil—UPP2—central nervous system—amyotrophic lateral sclerosis	0.00429	0.0574	CbGeAlD
Fluorouracil—Myocardial ischaemia—Riluzole—amyotrophic lateral sclerosis	0.00392	0.0265	CcSEcCtD
Fluorouracil—Cellulitis—Riluzole—amyotrophic lateral sclerosis	0.00347	0.0234	CcSEcCtD
Fluorouracil—UPP2—brain—amyotrophic lateral sclerosis	0.00341	0.0456	CbGeAlD
Fluorouracil—UMPS—medulla oblongata—amyotrophic lateral sclerosis	0.00336	0.0451	CbGeAlD
Fluorouracil—Leukocytosis—Riluzole—amyotrophic lateral sclerosis	0.00335	0.0227	CcSEcCtD
Fluorouracil—Dysarthria—Riluzole—amyotrophic lateral sclerosis	0.00333	0.0225	CcSEcCtD
Fluorouracil—Ulcer—Riluzole—amyotrophic lateral sclerosis	0.00333	0.0225	CcSEcCtD
Fluorouracil—Dermatitis contact—Riluzole—amyotrophic lateral sclerosis	0.00311	0.021	CcSEcCtD
Fluorouracil—UPP1—medulla oblongata—amyotrophic lateral sclerosis	0.00308	0.0413	CbGeAlD
Fluorouracil—Photophobia—Riluzole—amyotrophic lateral sclerosis	0.00296	0.02	CcSEcCtD
Fluorouracil—Coma—Riluzole—amyotrophic lateral sclerosis	0.00288	0.0195	CcSEcCtD
Fluorouracil—UPP1—spinal cord—amyotrophic lateral sclerosis	0.00275	0.0368	CbGeAlD
Fluorouracil—Sepsis—Riluzole—amyotrophic lateral sclerosis	0.00273	0.0185	CcSEcCtD
Fluorouracil—Euphoric mood—Riluzole—amyotrophic lateral sclerosis	0.00271	0.0183	CcSEcCtD
Fluorouracil—Photosensitivity—Riluzole—amyotrophic lateral sclerosis	0.00261	0.0176	CcSEcCtD
Fluorouracil—UMPS—nervous system—amyotrophic lateral sclerosis	0.00253	0.0339	CbGeAlD
Fluorouracil—Amnesia—Riluzole—amyotrophic lateral sclerosis	0.00244	0.0165	CcSEcCtD
Fluorouracil—UMPS—central nervous system—amyotrophic lateral sclerosis	0.00243	0.0326	CbGeAlD
Fluorouracil—UMPS—cerebellum—amyotrophic lateral sclerosis	0.00238	0.0319	CbGeAlD
Fluorouracil—Cardiac failure—Riluzole—amyotrophic lateral sclerosis	0.00234	0.0158	CcSEcCtD
Fluorouracil—Gastrointestinal haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00229	0.0155	CcSEcCtD
Fluorouracil—Osteoarthritis—Riluzole—amyotrophic lateral sclerosis	0.00229	0.0155	CcSEcCtD
Fluorouracil—UPP1—cerebellum—amyotrophic lateral sclerosis	0.00218	0.0292	CbGeAlD
Fluorouracil—Cardiac arrest—Riluzole—amyotrophic lateral sclerosis	0.00218	0.0147	CcSEcCtD
Fluorouracil—PPAT—medulla oblongata—amyotrophic lateral sclerosis	0.00217	0.029	CbGeAlD
Fluorouracil—Ataxia—Riluzole—amyotrophic lateral sclerosis	0.00215	0.0145	CcSEcCtD
Fluorouracil—Muscular weakness—Riluzole—amyotrophic lateral sclerosis	0.00202	0.0136	CcSEcCtD
Fluorouracil—Dysphagia—Riluzole—amyotrophic lateral sclerosis	0.00198	0.0134	CcSEcCtD
Fluorouracil—PPAT—spinal cord—amyotrophic lateral sclerosis	0.00193	0.0259	CbGeAlD
Fluorouracil—UMPS—brain—amyotrophic lateral sclerosis	0.00193	0.0259	CbGeAlD
Fluorouracil—Angina pectoris—Riluzole—amyotrophic lateral sclerosis	0.00193	0.013	CcSEcCtD
Fluorouracil—Pancytopenia—Riluzole—amyotrophic lateral sclerosis	0.00188	0.0127	CcSEcCtD
Fluorouracil—Photosensitivity reaction—Riluzole—amyotrophic lateral sclerosis	0.0018	0.0122	CcSEcCtD
Fluorouracil—Pneumonia—Riluzole—amyotrophic lateral sclerosis	0.00177	0.012	CcSEcCtD
Fluorouracil—UPP1—brain—amyotrophic lateral sclerosis	0.00177	0.0237	CbGeAlD
Fluorouracil—Infestation NOS—Riluzole—amyotrophic lateral sclerosis	0.00176	0.0119	CcSEcCtD
Fluorouracil—Infestation—Riluzole—amyotrophic lateral sclerosis	0.00176	0.0119	CcSEcCtD
Fluorouracil—Acute coronary syndrome—Riluzole—amyotrophic lateral sclerosis	0.00174	0.0117	CcSEcCtD
Fluorouracil—Myocardial infarction—Riluzole—amyotrophic lateral sclerosis	0.00173	0.0117	CcSEcCtD
Fluorouracil—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.00173	0.0117	CcSEcCtD
Fluorouracil—Stomatitis—Riluzole—amyotrophic lateral sclerosis	0.00172	0.0116	CcSEcCtD
Fluorouracil—Urinary tract infection—Riluzole—amyotrophic lateral sclerosis	0.00171	0.0116	CcSEcCtD
Fluorouracil—Epistaxis—Riluzole—amyotrophic lateral sclerosis	0.00166	0.0112	CcSEcCtD
Fluorouracil—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.00165	0.0112	CcSEcCtD
Fluorouracil—Agranulocytosis—Riluzole—amyotrophic lateral sclerosis	0.00165	0.0111	CcSEcCtD
Fluorouracil—PPAT—nervous system—amyotrophic lateral sclerosis	0.00163	0.0218	CbGeAlD
Fluorouracil—Haemoglobin—Riluzole—amyotrophic lateral sclerosis	0.00159	0.0107	CcSEcCtD
Fluorouracil—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.00159	0.0107	CcSEcCtD
Fluorouracil—Haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00158	0.0107	CcSEcCtD
Fluorouracil—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.00157	0.0106	CcSEcCtD
Fluorouracil—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.00157	0.0106	CcSEcCtD
Fluorouracil—PPAT—central nervous system—amyotrophic lateral sclerosis	0.00157	0.021	CbGeAlD
Fluorouracil—PPAT—cerebellum—amyotrophic lateral sclerosis	0.00153	0.0205	CbGeAlD
Fluorouracil—TYMP—medulla oblongata—amyotrophic lateral sclerosis	0.00145	0.0194	CbGeAlD
Fluorouracil—DPYD—brain—amyotrophic lateral sclerosis	0.00144	0.0193	CbGeAlD
Fluorouracil—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.00141	0.00955	CcSEcCtD
Fluorouracil—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.0014	0.00945	CcSEcCtD
Fluorouracil—TYMP—spinal cord—amyotrophic lateral sclerosis	0.00129	0.0173	CbGeAlD
Fluorouracil—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.00127	0.0086	CcSEcCtD
Fluorouracil—PPAT—brain—amyotrophic lateral sclerosis	0.00124	0.0167	CbGeAlD
Fluorouracil—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.00123	0.00833	CcSEcCtD
Fluorouracil—ABCC5—medulla oblongata—amyotrophic lateral sclerosis	0.00122	0.0163	CbGeAlD
Fluorouracil—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.00119	0.00807	CcSEcCtD
Fluorouracil—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00117	0.00792	CcSEcCtD
Fluorouracil—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00117	0.00792	CcSEcCtD
Fluorouracil—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.00116	0.00783	CcSEcCtD
Fluorouracil—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00113	0.00766	CcSEcCtD
Fluorouracil—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.00112	0.0076	CcSEcCtD
Fluorouracil—Oedema—Riluzole—amyotrophic lateral sclerosis	0.00112	0.0076	CcSEcCtD
Fluorouracil—Infection—Riluzole—amyotrophic lateral sclerosis	0.00112	0.00755	CcSEcCtD
Fluorouracil—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.0011	0.00745	CcSEcCtD
Fluorouracil—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.0011	0.00744	CcSEcCtD
Fluorouracil—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.0011	0.00741	CcSEcCtD
Fluorouracil—TYMP—nervous system—amyotrophic lateral sclerosis	0.00109	0.0146	CbGeAlD
Fluorouracil—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00107	0.00724	CcSEcCtD
Fluorouracil—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.00105	0.0071	CcSEcCtD
Fluorouracil—TYMP—central nervous system—amyotrophic lateral sclerosis	0.00105	0.0141	CbGeAlD
Fluorouracil—TYMP—cerebellum—amyotrophic lateral sclerosis	0.00103	0.0137	CbGeAlD
Fluorouracil—MTHFR—nervous system—amyotrophic lateral sclerosis	0.00103	0.0137	CbGeAlD
Fluorouracil—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00102	0.00692	CcSEcCtD
Fluorouracil—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00102	0.00687	CcSEcCtD
Fluorouracil—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00101	0.00682	CcSEcCtD
Fluorouracil—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.001	0.00677	CcSEcCtD
Fluorouracil—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.001	0.00675	CcSEcCtD
Fluorouracil—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00099	0.00669	CcSEcCtD
Fluorouracil—MTHFR—central nervous system—amyotrophic lateral sclerosis	0.000987	0.0132	CbGeAlD
Fluorouracil—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.000977	0.0066	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.000971	0.00656	CcSEcCtD
Fluorouracil—MTHFR—cerebellum—amyotrophic lateral sclerosis	0.000965	0.0129	CbGeAlD
Fluorouracil—Pain—Riluzole—amyotrophic lateral sclerosis	0.000962	0.0065	CcSEcCtD
Fluorouracil—TYMS—nervous system—amyotrophic lateral sclerosis	0.000935	0.0125	CbGeAlD
Fluorouracil—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.000927	0.00626	CcSEcCtD
Fluorouracil—TYMS—central nervous system—amyotrophic lateral sclerosis	0.000901	0.0121	CbGeAlD
Fluorouracil—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.000893	0.00604	CcSEcCtD
Fluorouracil—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.000889	0.00601	CcSEcCtD
Fluorouracil—TYMS—cerebellum—amyotrophic lateral sclerosis	0.00088	0.0118	CbGeAlD
Fluorouracil—ABCC5—cerebellum—amyotrophic lateral sclerosis	0.00086	0.0115	CbGeAlD
Fluorouracil—SLC29A1—nervous system—amyotrophic lateral sclerosis	0.000839	0.0112	CbGeAlD
Fluorouracil—TYMP—brain—amyotrophic lateral sclerosis	0.000833	0.0112	CbGeAlD
Fluorouracil—SLC22A7—brain—amyotrophic lateral sclerosis	0.000831	0.0111	CbGeAlD
Fluorouracil—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.000828	0.0056	CcSEcCtD
Fluorouracil—SLC29A1—central nervous system—amyotrophic lateral sclerosis	0.000808	0.0108	CbGeAlD
Fluorouracil—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.000796	0.00537	CcSEcCtD
Fluorouracil—SLC29A1—cerebellum—amyotrophic lateral sclerosis	0.000789	0.0106	CbGeAlD
Fluorouracil—MTHFR—brain—amyotrophic lateral sclerosis	0.000784	0.0105	CbGeAlD
Fluorouracil—CYP2A6—cerebellum—amyotrophic lateral sclerosis	0.000771	0.0103	CbGeAlD
Fluorouracil—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.000769	0.0052	CcSEcCtD
Fluorouracil—ABCC3—nervous system—amyotrophic lateral sclerosis	0.000767	0.0103	CbGeAlD
Fluorouracil—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.000744	0.00502	CcSEcCtD
Fluorouracil—ABCC3—central nervous system—amyotrophic lateral sclerosis	0.000739	0.00989	CbGeAlD
Fluorouracil—TYMS—brain—amyotrophic lateral sclerosis	0.000715	0.00958	CbGeAlD
Fluorouracil—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.000715	0.00483	CcSEcCtD
Fluorouracil—Rash—Riluzole—amyotrophic lateral sclerosis	0.000709	0.00479	CcSEcCtD
Fluorouracil—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.000708	0.00479	CcSEcCtD
Fluorouracil—Headache—Riluzole—amyotrophic lateral sclerosis	0.000704	0.00476	CcSEcCtD
Fluorouracil—ABCC5—brain—amyotrophic lateral sclerosis	0.000698	0.00935	CbGeAlD
Fluorouracil—Nausea—Riluzole—amyotrophic lateral sclerosis	0.000668	0.00451	CcSEcCtD
Fluorouracil—SLC29A1—brain—amyotrophic lateral sclerosis	0.000641	0.00859	CbGeAlD
Fluorouracil—ABCC4—nervous system—amyotrophic lateral sclerosis	0.000633	0.00848	CbGeAlD
Fluorouracil—CYP2A6—brain—amyotrophic lateral sclerosis	0.000626	0.00839	CbGeAlD
Fluorouracil—ABCC4—central nervous system—amyotrophic lateral sclerosis	0.00061	0.00817	CbGeAlD
Fluorouracil—ABCG2—medulla oblongata—amyotrophic lateral sclerosis	0.000595	0.00797	CbGeAlD
Fluorouracil—ABCC3—brain—amyotrophic lateral sclerosis	0.000586	0.00785	CbGeAlD
Fluorouracil—ABCG2—spinal cord—amyotrophic lateral sclerosis	0.000531	0.00711	CbGeAlD
Fluorouracil—ALB—brain—amyotrophic lateral sclerosis	0.0005	0.0067	CbGeAlD
Fluorouracil—ABCC4—brain—amyotrophic lateral sclerosis	0.000484	0.00648	CbGeAlD
Fluorouracil—ABCG2—cerebellum—amyotrophic lateral sclerosis	0.000421	0.00563	CbGeAlD
Fluorouracil—CYP2C8—brain—amyotrophic lateral sclerosis	0.000351	0.00471	CbGeAlD
Fluorouracil—ABCG2—brain—amyotrophic lateral sclerosis	0.000342	0.00458	CbGeAlD
Fluorouracil—ABCC4—Platelet degranulation—VEGFA—amyotrophic lateral sclerosis	0.000118	0.00112	CbGpPWpGaD
Fluorouracil—ABCC4—Platelet activation, signaling and aggregation—PLA2G4A—amyotrophic lateral sclerosis	0.000118	0.00112	CbGpPWpGaD
Fluorouracil—SLC22A7—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000118	0.00112	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000117	0.00111	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—VCP—amyotrophic lateral sclerosis	0.000116	0.0011	CbGpPWpGaD
Fluorouracil—TYMS—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	0.000116	0.0011	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—PLB1—amyotrophic lateral sclerosis	0.000113	0.00108	CbGpPWpGaD
Fluorouracil—ABCC3—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000113	0.00108	CbGpPWpGaD
Fluorouracil—ABCC3—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000113	0.00108	CbGpPWpGaD
Fluorouracil—ABCC4—Response to elevated platelet cytosolic Ca2+—VEGFA—amyotrophic lateral sclerosis	0.000112	0.00107	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000112	0.00107	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000111	0.00106	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—DAO—amyotrophic lateral sclerosis	0.000111	0.00106	CbGpPWpGaD
Fluorouracil—ALB—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.000111	0.00106	CbGpPWpGaD
Fluorouracil—UMPS—Metabolism—APOE—amyotrophic lateral sclerosis	0.000111	0.00105	CbGpPWpGaD
Fluorouracil—CYP1A2—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000111	0.00105	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000109	0.00104	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000108	0.00103	CbGpPWpGaD
Fluorouracil—TYMS—Retinoblastoma (RB) in Cancer—TP53—amyotrophic lateral sclerosis	0.000107	0.00102	CbGpPWpGaD
Fluorouracil—ABCC4—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000106	0.00101	CbGpPWpGaD
Fluorouracil—ABCC4—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000106	0.00101	CbGpPWpGaD
Fluorouracil—CYP2A6—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000104	0.000994	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000104	0.000993	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000104	0.000987	CbGpPWpGaD
Fluorouracil—UPP2—Metabolism—APOE—amyotrophic lateral sclerosis	0.000103	0.000981	CbGpPWpGaD
Fluorouracil—UPP1—Metabolism—APOE—amyotrophic lateral sclerosis	0.000103	0.000981	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000102	0.000972	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—KIFAP3—amyotrophic lateral sclerosis	0.000101	0.000967	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—VCP—amyotrophic lateral sclerosis	0.000101	0.000961	CbGpPWpGaD
Fluorouracil—ABCC3—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000101	0.00096	CbGpPWpGaD
Fluorouracil—ABCG2—HIF-1-alpha transcription factor network—VEGFA—amyotrophic lateral sclerosis	0.000101	0.00096	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—GSR—amyotrophic lateral sclerosis	0.0001	0.000958	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	9.97e-05	0.00095	CbGpPWpGaD
Fluorouracil—CYP2C8—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	9.91e-05	0.000945	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	9.8e-05	0.000934	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	9.74e-05	0.000928	CbGpPWpGaD
Fluorouracil—TYMS—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	9.58e-05	0.000913	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—PLB1—amyotrophic lateral sclerosis	9.48e-05	0.000903	CbGpPWpGaD
Fluorouracil—ABCC4—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	9.48e-05	0.000903	CbGpPWpGaD
Fluorouracil—ALB—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	9.47e-05	0.000902	CbGpPWpGaD
Fluorouracil—DPYD—Metabolism—GSTP1—amyotrophic lateral sclerosis	9.43e-05	0.000899	CbGpPWpGaD
Fluorouracil—PPAT—Metabolism—GSTP1—amyotrophic lateral sclerosis	9.43e-05	0.000899	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—DAO—amyotrophic lateral sclerosis	9.22e-05	0.000879	CbGpPWpGaD
Fluorouracil—ABCG2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	9.17e-05	0.000874	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	9.12e-05	0.000869	CbGpPWpGaD
Fluorouracil—TYMS—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	8.89e-05	0.000847	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—VAPB—amyotrophic lateral sclerosis	8.79e-05	0.000838	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—TPK1—amyotrophic lateral sclerosis	8.79e-05	0.000838	CbGpPWpGaD
Fluorouracil—ALB—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	8.78e-05	0.000837	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—GSR—amyotrophic lateral sclerosis	8.75e-05	0.000834	CbGpPWpGaD
Fluorouracil—DPYD—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	8.67e-05	0.000826	CbGpPWpGaD
Fluorouracil—PPAT—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	8.67e-05	0.000826	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	8.52e-05	0.000812	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	8.48e-05	0.000808	CbGpPWpGaD
Fluorouracil—CYP1A2—Phase II conjugation—GSTP1—amyotrophic lateral sclerosis	8.47e-05	0.000807	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—PLB1—amyotrophic lateral sclerosis	8.44e-05	0.000805	CbGpPWpGaD
Fluorouracil—ALB—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	8.44e-05	0.000804	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—CST3—amyotrophic lateral sclerosis	8.32e-05	0.000793	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—CHAT—amyotrophic lateral sclerosis	8.25e-05	0.000786	CbGpPWpGaD
Fluorouracil—ALB—Platelet degranulation—IGF1—amyotrophic lateral sclerosis	8.16e-05	0.000778	CbGpPWpGaD
Fluorouracil—CYP2C9—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	8.07e-05	0.000769	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—VAPA—amyotrophic lateral sclerosis	8.04e-05	0.000766	CbGpPWpGaD
Fluorouracil—ABCC4—Platelet activation, signaling and aggregation—IGF1—amyotrophic lateral sclerosis	8e-05	0.000762	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—VAPB—amyotrophic lateral sclerosis	7.99e-05	0.000761	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—TPK1—amyotrophic lateral sclerosis	7.99e-05	0.000761	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	7.97e-05	0.00076	CbGpPWpGaD
Fluorouracil—ABCG2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	7.8e-05	0.000743	CbGpPWpGaD
Fluorouracil—ABCG2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	7.8e-05	0.000743	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	7.79e-05	0.000743	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—GSR—amyotrophic lateral sclerosis	7.79e-05	0.000743	CbGpPWpGaD
Fluorouracil—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—amyotrophic lateral sclerosis	7.78e-05	0.000741	CbGpPWpGaD
Fluorouracil—UMPS—Metabolism—PTGS2—amyotrophic lateral sclerosis	7.58e-05	0.000723	CbGpPWpGaD
Fluorouracil—TYMS—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	7.55e-05	0.000719	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—SACM1L—amyotrophic lateral sclerosis	7.48e-05	0.000713	CbGpPWpGaD
Fluorouracil—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—amyotrophic lateral sclerosis	7.37e-05	0.000702	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—VAPA—amyotrophic lateral sclerosis	7.31e-05	0.000696	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	7.25e-05	0.000691	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—CST3—amyotrophic lateral sclerosis	7.24e-05	0.00069	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—CHAT—amyotrophic lateral sclerosis	7.18e-05	0.000685	CbGpPWpGaD
Fluorouracil—PPAT—Metabolism—APOE—amyotrophic lateral sclerosis	7.13e-05	0.00068	CbGpPWpGaD
Fluorouracil—DPYD—Metabolism—APOE—amyotrophic lateral sclerosis	7.13e-05	0.00068	CbGpPWpGaD
Fluorouracil—CYP2C8—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	7.12e-05	0.000679	CbGpPWpGaD
Fluorouracil—UPP2—Metabolism—PTGS2—amyotrophic lateral sclerosis	7.05e-05	0.000672	CbGpPWpGaD
Fluorouracil—UPP1—Metabolism—PTGS2—amyotrophic lateral sclerosis	7.05e-05	0.000672	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—TUBA4A—amyotrophic lateral sclerosis	7.03e-05	0.00067	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—FIG4—amyotrophic lateral sclerosis	7.03e-05	0.00067	CbGpPWpGaD
Fluorouracil—CYP2C8—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	7.02e-05	0.000669	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—PLB1—amyotrophic lateral sclerosis	6.99e-05	0.000666	CbGpPWpGaD
Fluorouracil—ABCG2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	6.95e-05	0.000662	CbGpPWpGaD
Fluorouracil—CYP1A2—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	6.89e-05	0.000657	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	6.81e-05	0.000649	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—SACM1L—amyotrophic lateral sclerosis	6.79e-05	0.000647	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—SOD1—amyotrophic lateral sclerosis	6.76e-05	0.000644	CbGpPWpGaD
Fluorouracil—TYMP—Metabolism—GSTP1—amyotrophic lateral sclerosis	6.72e-05	0.000641	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	6.71e-05	0.00064	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	6.68e-05	0.000636	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—RAB5A—amyotrophic lateral sclerosis	6.54e-05	0.000623	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—GSR—amyotrophic lateral sclerosis	6.45e-05	0.000615	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—CHAT—amyotrophic lateral sclerosis	6.4e-05	0.00061	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—FIG4—amyotrophic lateral sclerosis	6.39e-05	0.000609	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—DAO—amyotrophic lateral sclerosis	6.36e-05	0.000606	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—PFN1—amyotrophic lateral sclerosis	6.33e-05	0.000603	CbGpPWpGaD
Fluorouracil—ALB—Selenium Micronutrient Network—PTGS2—amyotrophic lateral sclerosis	6.27e-05	0.000598	CbGpPWpGaD
Fluorouracil—TYMP—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.18e-05	0.000589	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	6.07e-05	0.000578	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—CASP9—amyotrophic lateral sclerosis	6.05e-05	0.000576	CbGpPWpGaD
Fluorouracil—ALB—Platelet activation, signaling and aggregation—SOD1—amyotrophic lateral sclerosis	5.94e-05	0.000566	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	5.87e-05	0.00056	CbGpPWpGaD
Fluorouracil—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—amyotrophic lateral sclerosis	5.81e-05	0.000553	CbGpPWpGaD
Fluorouracil—CYP2C9—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	5.8e-05	0.000552	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—DAO—amyotrophic lateral sclerosis	5.78e-05	0.00055	CbGpPWpGaD
Fluorouracil—CYP2C9—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	5.72e-05	0.000545	CbGpPWpGaD
Fluorouracil—TYMS—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	5.7e-05	0.000543	CbGpPWpGaD
Fluorouracil—ALB—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	5.66e-05	0.000539	CbGpPWpGaD
Fluorouracil—TYMS—Circadian rythm related genes—TP53—amyotrophic lateral sclerosis	5.47e-05	0.000522	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	5.46e-05	0.000521	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—VAPB—amyotrophic lateral sclerosis	5.46e-05	0.00052	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—TPK1—amyotrophic lateral sclerosis	5.46e-05	0.00052	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—VAPB—amyotrophic lateral sclerosis	5.43e-05	0.000517	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—TPK1—amyotrophic lateral sclerosis	5.43e-05	0.000517	CbGpPWpGaD
Fluorouracil—ALB—Platelet degranulation—VEGFA—amyotrophic lateral sclerosis	5.33e-05	0.000508	CbGpPWpGaD
Fluorouracil—ALB—Platelet activation, signaling and aggregation—PLA2G4A—amyotrophic lateral sclerosis	5.32e-05	0.000507	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—CHAT—amyotrophic lateral sclerosis	5.3e-05	0.000505	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—CASP9—amyotrophic lateral sclerosis	5.26e-05	0.000502	CbGpPWpGaD
Fluorouracil—ABCC4—Platelet activation, signaling and aggregation—VEGFA—amyotrophic lateral sclerosis	5.23e-05	0.000498	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—ERBB4—amyotrophic lateral sclerosis	5.18e-05	0.000493	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	5.09e-05	0.000485	CbGpPWpGaD
Fluorouracil—TYMP—Metabolism—APOE—amyotrophic lateral sclerosis	5.08e-05	0.000484	CbGpPWpGaD
Fluorouracil—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—amyotrophic lateral sclerosis	5.08e-05	0.000484	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	5.06e-05	0.000482	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—VAPA—amyotrophic lateral sclerosis	4.99e-05	0.000476	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—VAPA—amyotrophic lateral sclerosis	4.96e-05	0.000473	CbGpPWpGaD
Fluorouracil—CYP1A2—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	4.95e-05	0.000472	CbGpPWpGaD
Fluorouracil—DPYD—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.89e-05	0.000466	CbGpPWpGaD
Fluorouracil—PPAT—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.89e-05	0.000466	CbGpPWpGaD
Fluorouracil—CYP1A2—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	4.88e-05	0.000466	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	4.83e-05	0.000461	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—PLB1—amyotrophic lateral sclerosis	4.82e-05	0.000459	CbGpPWpGaD
Fluorouracil—ALB—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	4.81e-05	0.000458	CbGpPWpGaD
Fluorouracil—ALB—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	4.81e-05	0.000458	CbGpPWpGaD
Fluorouracil—ALB—Folate Metabolism—TP53—amyotrophic lateral sclerosis	4.7e-05	0.000448	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	4.67e-05	0.000445	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—SACM1L—amyotrophic lateral sclerosis	4.64e-05	0.000442	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—SACM1L—amyotrophic lateral sclerosis	4.61e-05	0.00044	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—ERBB4—amyotrophic lateral sclerosis	4.51e-05	0.000429	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—GSR—amyotrophic lateral sclerosis	4.45e-05	0.000424	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—TPK1—amyotrophic lateral sclerosis	4.44e-05	0.000423	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—VAPB—amyotrophic lateral sclerosis	4.44e-05	0.000423	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.43e-05	0.000423	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—PLB1—amyotrophic lateral sclerosis	4.38e-05	0.000417	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—FIG4—amyotrophic lateral sclerosis	4.36e-05	0.000416	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—FIG4—amyotrophic lateral sclerosis	4.34e-05	0.000413	CbGpPWpGaD
Fluorouracil—ALB—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	4.29e-05	0.000409	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	4.14e-05	0.000395	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—IGF1—amyotrophic lateral sclerosis	4.12e-05	0.000393	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.08e-05	0.000388	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—VAPA—amyotrophic lateral sclerosis	4.06e-05	0.000387	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—GSR—amyotrophic lateral sclerosis	4.04e-05	0.000385	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—APOE—amyotrophic lateral sclerosis	4e-05	0.000382	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—DAO—amyotrophic lateral sclerosis	3.95e-05	0.000376	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—DAO—amyotrophic lateral sclerosis	3.92e-05	0.000374	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.86e-05	0.000368	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—VAPB—amyotrophic lateral sclerosis	3.8e-05	0.000362	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—TPK1—amyotrophic lateral sclerosis	3.8e-05	0.000362	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—SACM1L—amyotrophic lateral sclerosis	3.78e-05	0.00036	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—CHAT—amyotrophic lateral sclerosis	3.65e-05	0.000348	CbGpPWpGaD
Fluorouracil—ALB—Platelet activation, signaling and aggregation—IGF1—amyotrophic lateral sclerosis	3.62e-05	0.000345	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—FIG4—amyotrophic lateral sclerosis	3.55e-05	0.000338	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.55e-05	0.000338	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	3.54e-05	0.000337	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—APOE—amyotrophic lateral sclerosis	3.49e-05	0.000332	CbGpPWpGaD
Fluorouracil—TYMP—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.48e-05	0.000332	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—VAPA—amyotrophic lateral sclerosis	3.47e-05	0.000331	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.44e-05	0.000328	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—APOE—amyotrophic lateral sclerosis	3.35e-05	0.00032	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—CHAT—amyotrophic lateral sclerosis	3.32e-05	0.000316	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	3.31e-05	0.000316	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—SACM1L—amyotrophic lateral sclerosis	3.23e-05	0.000308	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—DAO—amyotrophic lateral sclerosis	3.21e-05	0.000306	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.16e-05	0.000301	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—SOD1—amyotrophic lateral sclerosis	3.06e-05	0.000292	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—FIG4—amyotrophic lateral sclerosis	3.03e-05	0.000289	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—PLB1—amyotrophic lateral sclerosis	2.99e-05	0.000285	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—PLB1—amyotrophic lateral sclerosis	2.97e-05	0.000283	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—APOE—amyotrophic lateral sclerosis	2.92e-05	0.000278	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.85e-05	0.000271	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—GSR—amyotrophic lateral sclerosis	2.76e-05	0.000263	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	2.74e-05	0.000262	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—DAO—amyotrophic lateral sclerosis	2.74e-05	0.000262	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—GSR—amyotrophic lateral sclerosis	2.74e-05	0.000261	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—PTGS2—amyotrophic lateral sclerosis	2.74e-05	0.000261	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—VEGFA—amyotrophic lateral sclerosis	2.69e-05	0.000257	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.62e-05	0.000249	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—APOE—amyotrophic lateral sclerosis	2.6e-05	0.000248	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	2.51e-05	0.00024	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	2.5e-05	0.000238	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle—TP53—amyotrophic lateral sclerosis	2.47e-05	0.000235	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—PLB1—amyotrophic lateral sclerosis	2.43e-05	0.000232	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—PTGS2—amyotrophic lateral sclerosis	2.39e-05	0.000228	CbGpPWpGaD
Fluorouracil—ALB—Platelet activation, signaling and aggregation—VEGFA—amyotrophic lateral sclerosis	2.36e-05	0.000225	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.3e-05	0.000219	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—CHAT—amyotrophic lateral sclerosis	2.27e-05	0.000216	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—CHAT—amyotrophic lateral sclerosis	2.25e-05	0.000215	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—GSR—amyotrophic lateral sclerosis	2.25e-05	0.000214	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—APOE—amyotrophic lateral sclerosis	2.15e-05	0.000205	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—PLB1—amyotrophic lateral sclerosis	2.08e-05	0.000198	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	2.07e-05	0.000197	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	2.06e-05	0.000196	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	2.05e-05	0.000195	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—TP53—amyotrophic lateral sclerosis	2.04e-05	0.000194	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—PTGS2—amyotrophic lateral sclerosis	2e-05	0.000191	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.96e-05	0.000187	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—GSR—amyotrophic lateral sclerosis	1.92e-05	0.000183	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—IGF1—amyotrophic lateral sclerosis	1.87e-05	0.000178	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—CHAT—amyotrophic lateral sclerosis	1.84e-05	0.000176	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.8e-05	0.000172	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.78e-05	0.00017	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.78e-05	0.00017	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.75e-05	0.000167	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.68e-05	0.00016	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.64e-05	0.000156	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—CHAT—amyotrophic lateral sclerosis	1.58e-05	0.00015	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—APOE—amyotrophic lateral sclerosis	1.48e-05	0.000141	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.47e-05	0.000141	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.44e-05	0.000137	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.42e-05	0.000135	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.41e-05	0.000134	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—APOE—amyotrophic lateral sclerosis	1.35e-05	0.000128	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—VEGFA—amyotrophic lateral sclerosis	1.22e-05	0.000116	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.22e-05	0.000116	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.21e-05	0.000115	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.15e-05	0.00011	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.12e-05	0.000107	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.11e-05	0.000106	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.02e-05	9.69e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—GSTP1—amyotrophic lateral sclerosis	9.91e-06	9.45e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	9.85e-06	9.39e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—PTGS2—amyotrophic lateral sclerosis	9.24e-06	8.8e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—TP53—amyotrophic lateral sclerosis	9.21e-06	8.78e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—APOE—amyotrophic lateral sclerosis	9.21e-06	8.78e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—APOE—amyotrophic lateral sclerosis	9.16e-06	8.73e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	9.11e-06	8.68e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	8.47e-06	8.07e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	7.78e-06	7.42e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—APOE—amyotrophic lateral sclerosis	7.49e-06	7.14e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—APOE—amyotrophic lateral sclerosis	6.4e-06	6.1e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.31e-06	6.01e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.27e-06	5.98e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.14e-06	4.89e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.39e-06	4.18e-05	CbGpPWpGaD
